Articles citing this paper
E-Cadherin Aptamer-Conjugated Delivery of Doxorubicin for Targeted Inhibition of Prostate Cancer Cells
Resham Chaudhary A , Kislay Roy A , Rupinder K. Kanwar A , Rakesh N. Veedu B C , Subramanian Krishnakumar D E , Chun Hei Antonio Cheung F G , Anita K. Verma H and Jagat R. Kanwar A IA Nanomedicine Laboratory of Immunology and Molecular Biomedical Research (NLIMBR), Centre for Molecular and Medical Research (C-MMR), School of Medicine (SoM), Faculty of Health, Deakin University, Waurn Ponds, Vic. 3217, Australia.
B Centre for Comparative Genomics, Murdoch University, Perth, WA 6150, Australia.
C Western Australian Neuroscience Research Institute, Perth, WA 6150, Australia.
D Department of Nanobiotechnology, Kamalnayan Bajaj Institute for Research in Vision and Ophthalmology, Chennai, Tamil Nadu 600006, India.
E Larsen and Toubro Department of Opthalmology, Vision Research Foundation, Kamalnayan Bajaj Institute for Research in Vision and Ophthalmology, Chennai, Tamil Nadu 600006, India.
F Department of Pharmacology, College of Medicine, National Cheng Kung University, Tainan 701, Taiwan.
G Institute of Basic Medical Sciences, College of Medicine, National Cheng Kung University, Tainan 704, Taiwan.
H Nanobiotech Laboratory, Department of Zoology, Kirorimal College, University of Delhi, Delhi 110007, India.
I Corresponding author. Email: jagat.kanwar@deakin.edu.au
Australian Journal of Chemistry 69(10) 1108-1116 https://doi.org/10.1071/CH16211
Submitted: 31 March 2016 Accepted: 20 July 2016 Published: 24 August 2016
